CNTB 1 (-1.96%)
US2075231017BiotechnologyBiotechnology

Connect Biopharma Holdings (CNTB) Stock Highlights

1 | -1.96%
2024-08-28 05:34:29
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233.

Statistics

Range Today
1 1.1
Volume Today 7.1K
Range 1 Year
0.54 2.84
Volume 1 Year 42.06M
Range 3 Year
0.54 25.25
Volume 3 Year 174.67M
Range 10 Year
0.54 29.27
Volume 10 Year 187.92M

Highlights

Market Capitalization 56.32M (small)
Floating Shares 14.64M
Current Price 1
Price To Earnings -0.94
Price To Book 0.56
Earnings Per Share -1.08
Payout Ratio 0%

Performance

Latest -1.96%
1 Month -20%
3 Months -40.83%
6 Months -17.36%
1 Year +25%
3 Years -95.04%
5 Years -94.88%
10 Years -94.88%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.